Department of Cardiac Arrhythmia, National Institute of Cardiology, Warsaw, Poland; Collegium Medicum, University of Cardinal Wyszynski in Warsaw, Warsaw, Poland
School of Public Health, Centre of Postgraduate Medical Education, Warsaw, Poland.
Pol Arch Intern Med. 2020 Jun 25;130(6):501-505. doi: 10.20452/pamw.15414. Epub 2020 Jun 3.
The coronavirus disease 2019 (COVID 19) is a communicable disease caused by a novel coronavirus.
This study aimed to assess self‑reported frequency of gastrointestinal symptoms and olfactory or taste disorders in nonhospitalized patients with COVID‑19 in Poland.
This cross‑sectional survey was conducted between April 17 and 18, 2020, in 4516 nonhospitalized patients with COVID‑19 in Poland. The questionnaire included 8 questions related to the health status, symptoms of COVID‑19, comorbidities, and smoking status.
Completed questionnaires were obtained from 1942 patients with COVID‑19 with a response rate of 43%. The median age of the respondents was 50 years; 60.2% were women. Among nonhospitalized patients with COVID‑19, 21.3% had hypertension, 4.5% had diabetes, and 3.1% had a chronic respiratory disease. Regular tobacco use was declared by 11.2% of patients with COVID‑19. At least one gastrointestinal symptom was reported by 53.6% of patients. Almost half of patients (47%) with COVID‑19 reported lack of appetite and 24.2% reported diarrhea. Among 1942 interviewed patients, 54.2% reported at least 1 olfactory or taste disorder and 42.5% reported both alterations. Self‑reported olfactory and taste disorders were 49.2% and 47.5%, respectively. Self‑reported frequency of gastrointestinal symptoms and olfactory or taste disorders during COVID‑19 was significantly higher (P <0.001) in women than men.
This study demonstrated that olfactory and taste disorders are frequent symptoms in patients with mild‑to‑moderate COVID‑19. Moreover, our study indicated sex differences in the frequency of gastrointestinal symptoms and olfactory or taste disorders among nonhospitalized patients with COVID‑19.
2019 年冠状病毒病(COVID-19)是一种由新型冠状病毒引起的传染性疾病。
本研究旨在评估波兰非住院 COVID-19 患者的胃肠道症状和嗅觉或味觉障碍的自我报告频率。
这项横断面调查于 2020 年 4 月 17 日至 18 日在波兰的 4516 名非住院 COVID-19 患者中进行。问卷包括 8 个与健康状况、COVID-19 症状、合并症和吸烟状况相关的问题。
从 1942 名 COVID-19 患者中获得了完整的问卷,应答率为 43%。受访者的中位年龄为 50 岁;60.2%为女性。在非住院 COVID-19 患者中,21.3%有高血压,4.5%有糖尿病,3.1%有慢性呼吸系统疾病。11.2%的 COVID-19 患者有规律的烟草使用。53.6%的患者至少有一种胃肠道症状。近一半的 COVID-19 患者(47%)报告食欲不振,24.2%报告腹泻。在接受采访的 1942 名患者中,54.2%报告至少有一种嗅觉或味觉障碍,42.5%报告同时存在两种改变。自我报告的嗅觉和味觉障碍分别为 49.2%和 47.5%。COVID-19 期间女性自我报告的胃肠道症状和嗅觉或味觉障碍的频率明显高于男性(P<0.001)。
本研究表明,嗅觉和味觉障碍是轻度至中度 COVID-19 患者的常见症状。此外,我们的研究表明,非住院 COVID-19 患者中胃肠道症状和嗅觉或味觉障碍的频率存在性别差异。